FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA WEBVIEW CLOSED JULY 4TH WEEK

[ Price : $8.95]

In annual observance of the Fourth of July (Independence Day) holiday in the U.S., FDA Webview closes its news operations until Mo...

Brookfield Medical/Surgical FDA-483

[ Price : $8.95]

FDA releases the form FDA-483 with four observations from an inspection at the Brookfield, CT-based Brookfield Medical/Surgical Su...

Complete Response on Rocket Gene Therapy

[ Price : $8.95]

FDA issues Rocket Pharmaceuticals a complete response letter on its BLA for gene therapy Kresladi (marnetegragene autotemcel; marn...

Shorla Oncology Breast/Ovarian Cancer Drug OKd

[ Price : $8.95]

FDA approves a Shorla Oncology NDA for Tepylute (thiotepa), a ready-to-dilute formulation for treating breast and ovarian cancer.

Promising Myasthenia Gravis Trial Data: J&J

[ Price : $8.95]

Johnson & Johnson reports positive data from its Phase 3 Vivacity-MG3 study of nipocalimab in patients with generalized myasthenia...

Praise for Biological Labeling Draft Guidance

[ Price : $8.95]

The Biosimilars Council and Biosimilars Forum praise a revised FDA draft guidance on biosimilar promotional labeling.

Drug Delivery Device Guidance

[ Price : $8.95]

FDA publishes a draft guidance recommending medical device design outputs essential for establishing and assessing drug delivery p...

Philips Updates BiPAP Ventilator Use Instructions

[ Price : $8.95]

FDA says Philips Respironics has updated use instructions for three BiPAP ventilators in a Class 1 recall.

SCOTUS Chevron Decision Harms the Public: Coalition

[ Price : $8.95]

The Coalition for Sensible Safeguards calls on Congress to enact Chevron deference into law following a Supreme Court decision gut...

Abbott Recalls HeartMate System Monitor

[ Price : $8.95]

Abbott Medical recalls (Class 1) its HeartMate System Monitor due to atypical behavior of the System Monitor screen.